GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 10:05:04 16/01/2026 pm IST			5-day change	1st Jan Change
1,816.50 ^GBX	-1.70%		-3.69%	-0.44%

16/01	Where the Money's Moving
16/01	Some drugmakers quietly concerned about legal risk with speedy FDA review program	RE

Transcript : GSK plc Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025

Published on 12/12/2025 at 10:20 pm IST

S&P Capital IQ

Presenter Speech
Graham Glyn Parry (Analysts)

So we're ready now to start the next session. It's my pleasure to be able to introduce GSK. And from GSK, we have Deborah Waterhouse, who's the CEO of

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about GSK plc

16/01	Where the Money's Moving
16/01	Some drugmakers quietly concerned about legal risk with speedy FDA review program	RE
16/01	GSK : UBS sticks Neutral	ZD
16/01	GSK : Gets a Neutral rating from Deutsche Bank	ZD
16/01	BofA cuts British Land; RBC raises Gym Group	AN
15/01	Stocks in green as US manufacturing surprises	AN
15/01	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
15/01	European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading	MT
15/01	GSK : Barclays reaffirms its Sell rating	ZD
14/01	GSK : JP Morgan reaffirms its Sell rating	ZD
14/01	GSK plc Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 07:30 AM
13/01	Global drugmakers rush to boost US presence as tariff threat looms	RE
13/01	Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026	CI
12/01	Haisco Pharmaceutical Group Co., Ltd. Enters into an Exclusive Licensing Agreement with AirNexis	CI
12/01	Summit Therapeutics, GSK Team up on Clinical Trial for Combination Cancer Therapy	MT
12/01	Summit Therapeutics Announces Clinical Trial Collaboration with GSK plc to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate	CI
09/01	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026	RE
09/01	AnaptysBio Moves to Dismiss GSK's Tesaro Lawsuit Over Jemperli Royalty Dispute	MT
09/01	Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026	CI
09/01	UK Stocks-Factors to watch on January 9	RE
09/01	Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices	DJ
09/01	AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty	RE
09/01	AnaptysBio Files to Dismiss Tesaro's Claim it Breached Royalties Contract	DJ
09/01	Anaptys files motion to dismiss Tesaro's claim of anticipatory breach of contract in ongoing litigation	RE
09/01	Praxis Precision Medicines, Inc. Announces Management Changes	CI